Dikloksasilin etkileşimleri

In vitro mixing of penicillins and aminoglycosides should be avoided during concomitant therapy and the drugs should be administered separately. (Dikloksasilin etiketi, İlaç etkileşimleri)

AMOXIL is contraindicated in patients who have experienced a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to AMOXIL or to other β-lactam antibacterial drugs (e.g., penicillins and cephalosporins). (Amoksisilin etiketi, Kontrendikasyonlar)

History of a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to AUGMENTIN or to other beta‑lactams (e.g., penicillins or cephalosporins). (Amoksisilin ve klavulanat etiketi, Kontrendikasyonlar)

CONTRAINDICATIONS The use of Ampicillin is contraindicated in individuals with a history of serious hypersensitivity reactions (e.g., anaphylaxis or Stevens-Johnson syndrome) to ampicillin or to other beta-lactam antibacterial drugs. (Ampisilin etiketi, Kontrendikasyonlar)

CONTRAINDICATIONS The use of UNASYN is contraindicated in individuals with a history of serious hypersensitivity reactions (e.g., anaphylaxis or Stevens-Johnson syndrome) to ampicillin, sulbactam or to other beta-lactam antibacterial drugs (e.g., penicillins and cephalosporins). (Ampisilin ve sulbaktam etiketi, Kontrendikasyonlar)

Drug Interactions Tetracycline, a bacteriostatic antibiotic, may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided. (Dikloksasilin etiketi, İlaç etkileşimleri)

Since bacteriostatic drugs may interfere with the bactericidal action of penicillins, it is advisable to avoid giving tetracycline-class drugs in conjunction with penicillin. (Demeklosiklin etiketi, İlaç etkileşimleri)

Avoid co-administration of tetracyclines with penicillin. (Doksisiklin etiketi, İlaç etkileşimleri)

INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (Ertapenem etiketi, Kontrendikasyonlar)

In vitro mixing of penicillins and aminoglycosides should be avoided during concomitant therapy and the drugs should be administered separately. (Dikloksasilin etiketi, İlaç etkileşimleri)

Hypersensitivity Reactions: Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving therapy with beta-lactams. (İmipenem ve silastatin etiketi, Uyarılar ve önlemler)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (Minosiklin etiketi, İlaç etkileşimleri)

In vitro mixing of penicillins and aminoglycosides should be avoided during concomitant therapy and the drugs should be administered separately. (Dikloksasilin etiketi, İlaç etkileşimleri)

In vitro mixing of penicillins and aminoglycosides should be avoided during concomitant therapy and the drugs should be administered separately. (Dikloksasilin etiketi, İlaç etkileşimleri)

Hypersensitivity to cefazolin or other cephalosporin class antibacterial drugs, penicillins, or other beta-lactams (4.1) (Sefazolin etiketi, Kontrendikasyonlar)

Patients with known immediate hypersensitivity reactions to cefepime or other cephalosporins, penicillins or other beta-lactam antibacterial drugs. (Sefepim etiketi, Kontrendikasyonlar)

Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Sefoksitin etiketi, Kontrendikasyonlar)

Hypersensitivity Reactions Serious and occasionally fatal hypersensitivity (anaphylactic) reactions and serious skin reactions have been reported in patients receiving beta-lactam antibacterial drugs. (Seftarolin etiketi, Uyarılar ve önlemler)

Anaphylaxis to ceftriaxone or other cephalosporin class antibacterials, penicillins, or other beta-lactam antibacterials ( 4.1 ) (Seftriakson etiketi, Kontrendikasyonlar)

Cefuroxime axetil is contraindicated in patients with a known hypersensitivity (e.g., anaphylaxis) to cefuroxime axetil or to other β-lactam antibacterial drugs (e.g., penicillins and cephalosporins). (Sefuroksim etiketi, Kontrendikasyonlar)

Drug Interactions Tetracycline, a bacteriostatic antibiotic, may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided. (Dikloksasilin etiketi, İlaç etkileşimleri)

In vitro mixing of penicillins and aminoglycosides should be avoided during concomitant therapy and the drugs should be administered separately. (Dikloksasilin etiketi, İlaç etkileşimleri)

Dicloxacillin may reduce the anticoagulant response to dicumarol and warfarin. (Dikloksasilin etiketi, İlaç etkileşimleri)

Dicloxacillin may reduce the anticoagulant response to dicumarol and warfarin. (Dikloksasilin etiketi, İlaç etkileşimleri)

Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam etiketi, Uyarılar ve önlemler)

Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (Benazepril ve hidroklorotiyazid etiketi, Uyarılar)

Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (Bisoprolol ve hidroklorotiyazid etiketi, Uyarılar)

Dicloxacillin may reduce the anticoagulant response to dicumarol and warfarin. (Dikloksasilin etiketi, İlaç etkileşimleri)

Dicloxacillin may reduce the anticoagulant response to dicumarol and warfarin. (Dikloksasilin etiketi, İlaç etkileşimleri)

Drugs that Cause Hypokalemia The risk of hypokalemia is greater with coadministration of KEVEYIS and other drugs that can cause hypokalemia (e.g., loop diuretics, thiazide diuretics, laxatives, antifungals, penicillins, and theophylline) [see Warnings and Precautions (5.3) ] . (Diklorfenamid etiketi, İlaç etkileşimleri)

Dicloxacillin may reduce the anticoagulant response to dicumarol and warfarin. (Dikloksasilin etiketi, İlaç etkileşimleri)

Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (Enalapril ve hidroklorotiyazid etiketi, Uyarılar)

Dicloxacillin may reduce the anticoagulant response to dicumarol and warfarin. (Dikloksasilin etiketi, İlaç etkileşimleri)

Dicloxacillin may reduce the anticoagulant response to dicumarol and warfarin. (Dikloksasilin etiketi, İlaç etkileşimleri)

Dicloxacillin may reduce the anticoagulant response to dicumarol and warfarin. (Dikloksasilin etiketi, İlaç etkileşimleri)

Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (Hidroklorotiyazid etiketi, Uyarılar ve önlemler)

Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (İrbesartan ve hidroklorotiyazid etiketi, Uyarılar ve önlemler)

Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (Kandesartan ve hidroklorotiyazid etiketi, Uyarılar)

Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (Kinapril ve hidroklorotiyazid etiketi, Uyarılar)

The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride. (Kolestipol etiketi, İlaç etkileşimleri)

Drug Interactions Cholestyramine for Oral Suspension USP may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic), or propranolol (basic), as well as tetracycline, penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis. (Kolestiramin etiketi, İlaç etkileşimleri)

In patients taking ARAVA, exposure of drugs which are OAT3 substrates (e.g., cefaclor, cimetidine, ciprofloxacin, penicillin G, ketoprofen, furosemide, methotrexate, zidovudine) may be increased. (Leflunomid etiketi, İlaç etkileşimleri)

Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (Lisinopril ve hidroklorotiyazid etiketi, Uyarılar)

Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (Losartan ve hidroklorotiyazid etiketi, Uyarılar ve önlemler)

Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (Metoprolol ve hidroklorotiyazid etiketi, Uyarılar ve önlemler)

Effect of Other Drugs on XATMEP Oral Antibiotics Penicillins may reduce the renal clearance of methotrexate; increased serum concentrations of methotrexate with concomitant hematologic and gastrointestinal toxicity have been observed with methotrexate. (Metotreksat etiketi, İlaç etkileşimleri)

Examples Cyclosporine A, trimethoprim/sulfamethoxazole, bile acid sequestrants (cholestyramine), rifampin as well as aminoglycoside, cephalosporin, fluoroquinolone and penicillin classes of antimicrobials Drugs Modulating Glucuronidation Clinical Impact Concomitant use with drugs inducing glucuronidation decreases MPA systemic exposure, potentially reducing mycophenolate… (Mikofenolat etiketi, İlaç etkileşimleri)

Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (Olmesartan ve hidroklorotiyazid etiketi, Uyarılar ve önlemler)

Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (Olmesartan, amlodipin ve hidroklorotiyazid etiketi, Uyarılar ve önlemler)

Other drugs may compete with penicillin G for renal tubular secretion and thus prolong the serum half-life of penicillin. (Penisilin G etiketi, İlaç etkileşimleri)

Nephrotoxicity in critically ill patients has been observed; the use of piperacillin and tazobactam was found to be an independent risk factor for renal failure and was associated with delayed recovery of renal function as compared to other beta-lactam antibacterial drugs in a randomized, multicenter, controlled trial in critically ill patients. (Piperasilin ve tazobaktam etiketi, Uyarılar ve önlemler)

Probenecid administered concomitantly with penicillins increases and prolongs serum penicillin levels (see DOSAGE AND ADMINISTRATION ). (Dikloksasilin etiketi, İlaç etkileşimleri)

Probenecid administered concomitantly with penicillins increases and prolongs serum penicillin levels (see DOSAGE AND ADMINISTRATION ). (Dikloksasilin etiketi, İlaç etkileşimleri)

Drug Interactions Protamine sulfate has been shown to be incompatible with certain antibiotics, including several of the cephalosporins and penicillins (see DOSAGE AND ADMINISTRATION ). (Protamin etiketi, Önlemler)

Dicloxacillin may reduce the anticoagulant response to dicumarol and warfarin. (Dikloksasilin etiketi, İlaç etkileşimleri)

Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids. [When Salsalate tablets, USP are administered with aspirin, its protein binding is reduced, although the clearance of free Salsalate tablets,… (Salsalat etiketi, İlaç etkileşimleri)

Warnings and Precautions BEFORE THERAPY WITH CEFADROXIL IS INSTITUTED, CAREFUL INQUIRY SHOULD BE MADE TO DETERMINE WHETHER THE PATIENT HAS HAD PREVIOUS HYPERSENSITIVITY REACTIONS TO CEFADROXIL, CEPHALOSPORINS, PENICILLINS, OR OTHER DRUGS. (Sefadroksil etiketi, Uyarılar ve önlemler)

IF THIS PRODUCT IS TO BE GIVEN TO PENICILLIN-SENSITIVE PATIENTS, CAUTION SHOULD BE EXERCISED BECAUSE CROSS-SENSITIVITY AMONG BETA-LACTAM ANTIBIOTICS HAS BEEN CLEARLY DOCUMENTED AND MAY OCCUR IN UP TO 10% OF PATIENTS WITH A HISTORY OF PENICILLIN ALLERGY. (Sefaklor etiketi, Uyarılar)

• Serious hypersensitivity (anaphylactic) reactions: Prior to use, inquire regarding history of hypersensitivity to beta-lactam antibacterial drugs. (Sefaleksin etiketi, Uyarılar ve önlemler)

IF CEFDINIR IS TO BE GIVEN TO PENICILLIN-SENSITIVE PATIENTS, CAUTION SHOULD BE EXERCISED BECAUSE CROSS-HYPERSENSITIVITY AMONG β-LACTAM ANTIBIOTICS HAS BEEN CLEARLY DOCUMENTED AND MAY OCCUR IN UP TO 10% OF PATIENTS WITH A HISTORY OF PENICILLIN ALLERGY. (Sefdinir etiketi, Uyarılar)

If this product is to be given to penicillin-sensitive patients, caution should be exercised because cross hypersensitivity among beta-lactam antibacterial drugs has been clearly documented and may occur in up to 10% of patients with a history of penicillin allergy. (Sefiksim etiketi, Uyarılar ve önlemler)

THIS PRODUCT SHOULD BE GIVEN WITH CAUTION TO PATIENTS WITH TYPE I HYPERSENSITIVITY REACTIONS TO PENICILLIN. (Sefotaksim etiketi, Uyarılar)

IF THIS PRODUCT IS TO BE GIVEN TO PENICILLIN-SENSITIVE PATIENTS, CAUTION SHOULD BE EXERCISED BECAUSE CROSS-HYPERSENSITIVITY AMONG BETA-LACTAM ANTIBIOTICS HAS BEEN CLEARLY DOCUMENTED AND MAY OCCUR IN UP TO 10% OF PATIENTS WITH A HISTORY OF PENICILLIN ALLERGY. (Sefotetan etiketi, Uyarılar)

IF CEFPODOXIME IS TO BE ADMINISTERED TO PENICILLIN SENSITIVE PATIENTS, CAUTION SHOULD BE EXERCISED BECAUSE CROSS HYPERSENSITIVITY AMONG BETA-LACTAM ANTIBIOTICS HAS BEEN CLEARLY DOCUMENTED AND MAY OCCUR IN UP TO 10% OF PATIENTS WITH A HISTORY OF PENICILLIN ALLERGY. (Sefpodoksim etiketi, Uyarılar)

IF THIS PRODUCT IS TO BE GIVEN TO PENICILLIN-SENSITIVE PATIENTS, CAUTION SHOULD BE EXERCISED BECAUSE CROSS-SENSITIVITY AMONG β-LACTAM ANTIBIOTICS HAS BEEN CLEARLY DOCUMENTED AND MAY OCCUR IN UP TO 10% OF PATIENTS WITH A HISTORY OF PENICILLIN ALLERGY. (Sefprozil etiketi, Uyarılar)

IF THIS PRODUCT IS TO BE GIVEN TO PENICILLIN-SENSITIVE PATIENTS, CAUTION SHOULD BE EXERCISED BECAUSE CROSS- HYPERSENSITIVITY AMONG BETA-LACTAM ANTIBACTERIAL DRUGS HAS BEEN CLEARLY DOCUMENTED AND MAY OCCUR IN UP TO 10% OF PATIENTS WITH A HISTORY OF PENICILLIN ALLERGY. (Seftazidim etiketi, Uyarılar)

Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (Spironolakton ve hidroklorotiyazid etiketi, Uyarılar)

Drugs that May Enhance the Neuromuscular Blocking Action of Succinylcholine : promazine, oxytocin, aprotinin, certain non-penicillin antibiotics, quinidine, β-adrenergic blockers, procainamide, lidocaine, trimethaphan, lithium carbonate, magnesium salts, quinine, chloroquine, isoflurane, desflurane, metoclopramide, terbutaline, and drugs that reduce plasma cholinesterase… (Süksinilkolin etiketi, İlaç etkileşimleri)

Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (Telmisartan ve hidroklorotiyazid etiketi, Uyarılar ve önlemler)

In patients taking AUBAGIO, exposure of drugs which are OAT3 substrates (e.g., cefaclor, cimetidine, ciprofloxacin, penicillin G, ketoprofen, furosemide, methotrexate, zidovudine) may be increased. (Teriflunomid etiketi, İlaç etkileşimleri)

…from blood bank (may contain up to 30 mEq of potassium per liter of plasma or up to 65 mEq per liter of whole blood when stored for more than 10 days); low-salt milk (may contain up to 60 mEq of potassium per liter); potassium-containing medications (such as parenteral penicillin G potassium); salt substitutes (most contain substantial amounts of potassium). (Triamteren etiketi, İlaç etkileşimleri)

Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (Triamteren ve hidroklorotiyazid etiketi, Uyarılar)

Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (Valsartan ve hidroklorotiyazid etiketi, Uyarılar ve önlemler)

Dicloxacillin may reduce the anticoagulant response to dicumarol and warfarin. (Dikloksasilin etiketi, İlaç etkileşimleri)

Infants born to women treated during pregnancy with oral erythromycin for early syphilis should be treated with an appropriate penicillin regimen. (Eritromisin etiketi, Uyarılar)

…Catheter-Related Bloodstream Infections, Including Those With Catheter-Site Infections An imbalance in mortality was seen in patients treated with linezolid relative to vancomycin/dicloxacillin/oxacillin in an open-label study in seriously ill patients with intravascular catheter-related infections [78/363 (21.5%) vs. 58/363 (16.0%); odds ratio 1.426, 95% CI… (Linezolid etiketi, Uyarılar ve önlemler)

There have been reports of individuals with a history of penicillin hypersensitivity who have experienced severe hypersensitivity reactions when treated with another β-lactam. (Meropenem etiketi, Uyarılar ve önlemler)

Patients who are allergic to penicillin may theoretically have cross-sensitivity to penicillamine. (Penisilamin etiketi, Önlemler)

Some antibiotics such as penicillin may compete with phenylacetylglutamine and hippurate for active secretion by renal tubules, which may affect the overall disposition of the infused drug. (Sodyum fenilasetat ve sodyum benzoat etiketi, İlaç etkileşimleri)

Drug Interactions Tetracycline, a bacteriostatic antibiotic, may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided. (Dikloksasilin etiketi, İlaç etkileşimleri)